1307. Emerging Treatments in Ongoing Battle Against Community-Acquired Bacterial Pneumonia (CABP): The Positive Impact of Online Education
Session: Poster Abstract Session: Medical Education
Friday, October 5, 2018
Room: S Poster Hall
  • Hurst-IDWeek2018-CABP_Final.pdf (168.9 kB)
  • Background: The leading infectious cause of hospitalization and infection-related mortality, pneumonia imparts a significant, but often underappreciated, burden. Agents in the antibiotic pipeline have the potential to improve both individual and public health, as well as support antibiotic stewardship programs

    Methods: To address knowledge gaps among ID specialists, a CME/CE-certified, 30-minute, video-based, multidisciplinary panel discussion was developed and posted online on 3/27/2018. Featuring 4 expert faculty, the activity addressed:

      The evolving etiology of CABP;

      Emerging antibiotics for CABP treatment; and

      Antibiotic stewardship

    Educational effectiveness was assessed with a repeated-pairs pre-/post-assessment study design, in which each individual served as his/her own control. Responses to multiple-choice, knowledge questions and a self-efficacy confidence question were analyzed. A chi-squared test assessed changes pre- to post-assessment. P values <0.05 are statistically significant. Effect sizes were evaluated using Cramer's V (<0.05 modest; 0.06-0.15 noticeable effect; 0.16-0.26 considerable effect; >0.26 extensive effect). Data were collected through 4/23/2017.

    Results: 6146 healthcare providers, including 2936 physicians have participated in the activity. Data from ID specialists (n=130) who answered all pre-/post-assessment questions during the study period were analyzed. Significant improvements were observed overall (P=.024; V=.080) and in several specific areas of assessment (Figure). Following activity participation, 34% of ID specialists indicated increased confidence in assessing key attributes of emerging agents and 79% of ID specialists indicated a commitment to incorporate one or more changes into practice. Lastly, the findings uncovered educational needs that require further educational intervention.

    Conclusion: Participation in this online educational intervention significantly improved ID specialists’ knowledge with regard to the key similarities and differences between agents in the CABP antibiotic pipeline and the potential role of these agents in patient care. These findings highlight the positive impact of well-designed online education.

    Simi Hurst, PhD, Medscape, LLC, New York, NY and Susan Smith, MN, PhD, Medscape Education, New York, NY


    S. Hurst, Nabriva Therapeutics: Independent Medical Education , Educational grant .

    S. Smith, Nabriva Therapeutics: Independent Medical Education , Educational grant .

    See more of: Medical Education
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.